IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Venrock Adviser, LLC

Portfolio Profile

CIK: 0001615982 | NEW YORK, NY

Investment Profile

Style

Growth

Turnover

Low

Orientation

Concentrated trader
$3.3B
AUM
33
Positions
80.39%
Top 10 Conc.
97.26%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Apogee Therapeutics Inc(APGE)8,493,321$1.1B34.18%
2Oruka Therapeutics Inc(ORKA)4,148,428$394.8M11.97%
3Erasca Inc(ERAS)17,891,812$327.8M9.94%
4Spyre Therapeutics Inc(SYRE)2,985,448$265.0M8.04%
5Dianthus Therapeutics Inc(DNTH)1,180,000$115.0M3.49%

Sector Allocation

Latest filing, equity positions only

Healthcare98.23% · $3.2B
Unclassified1.77% · $58.3M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.57%98.23%-0.34%
Unclassified1.43%1.77%+0.34%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$949.9M | 37 pos.
$1.5B | 36 pos.
$2.1B | 38 pos.
$1.6B | 35 pos.
$1.9B | 38 pos.
$1.5B | 37 pos.
6
Ocular Therapeutix Inc(OCUL)
10,346,926
$101.6M
3.08%
7Damora Therapeutics Inc(GLTO)3,603,595$93.7M2.84%
8Savara Inc(SVRA)14,745,943$90.8M2.75%
9Jade Biosciences Inc(JBIO)3,220,364$71.6M2.17%
10Cogent Biosciences Inc(COGT)1,642,166$63.6M1.93%
Cap SizePrev %Curr %Change
Mid Cap56.18%62.3%+6.12%
Small Cap39.2%33.11%-6.09%
Micro Cap3.19%2.82%-0.37%
Unclassified1.43%1.77%+0.34%
$1.2B | 37 pos.
$1.3B | 31 pos.
$1.8B | 33 pos.
$2.0B | 27 pos.
$2.7B | 33 pos.
$3.3B | 33 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

4
New
4
Closed
5
Increased
5
Decreased
19
Unchanged